Search
for
Sort by
Research 91–120 of 1000+
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Under Development JAK Inhibitors for Dermatologic Diseases
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Alopecia Areata
- Tofacitinib for the treatment of lichen planopilaris: A case series
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata
- Alopecia Universalis: Never Give Up?
- Alopecia areata in children: an overview of clinical features and recent treatment options
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- What’s new in the treatment of hair loss?
- Alopecia in general medicine
- Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata